Look, we already discussed this before, Sovaldi/Olysio can't compete on price. If you still think GILD is going to price Sofosbuvir/ledipasvir FDC anywhere close to Sovaldi/Olysio combo price, I don't really know what to say. If it can't compete on price in US, it can't compete on price anywhere else in the world.
Market Data 
Markets 
AI
